2 Results (Page 1 of 1)
France Free Sample Markets Research Reports
France Biosimilars Market Analysis Sample Report
France's biosimilars market size was valued at $0.5 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 21.4% from 2022 to 2030 and will reach $2.4 Bn in 2030. The market is segmented by product type and indication type. The France Biosimilars market will grow with the increased incidence of chronic illnesses, rising healthcare expenses, and the demand for affordable biologic medicine substitutes. The key market players are Sanofi, Pfizer, Biogen, Mylan, Amgen, and others.
France Patient Support Programs (PSP) Market Analysis Sample Report
The France patient support programs market is expected to grow as many of pharma companies are investing in the market in France. The market is segmented by functionality outlook, therapeutic area outlook, application outlook, and the end user. Major services include caregiver access, healthcare financing, and self-care.